Overall verdict
Neutral
5.3/10
1-year performance
+33.35%
Score breakdown
Up 33.4% over 1 year, 84% of the 52-week range.
Strongest: Shareholder return 5.7/10. Weakest: Financial strength 2.4/10.
19 analysts, target +0.1% vs the price.
Keurig Dr Pepper Inc. owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. The company operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. It manufactures and distributes branded concentrates, syrup, and finished beverages, as well as sales of owned brands and third-party brands; tea, cocoa, and other products; and offers finished goods relating to K-Cup pods, single serve brewers, specialty coffee, and ready to drink coffee products.
The company offers its products under the Dr Pepper, Canada Dry, Mott's, A&W, Peñafiel, GHOST, Snapple, 7UP, Green Mountain Coffee Roasters, Clamato, Core Hydration, The Original Donut Shop, Sunkist soda, Squirt, C4 Energy, Hawaiian Punch, Electrolit, Bloom, Bai, Evian, Yoo-Hoo, Vita Coco, Big Red, RC Cola, Crush, McCafé, Tim Hortons, Van Houtte, Celestial Seasonings, Bigelow, Starbucks, Dunkin', Folgers, Peet's, and Swiss Miss brands, as well as other partner and private label brands.
It markets and sells its products to supermarkets, mass merchandisers, club stores, e-commerce retailers, office superstores, vending machines, fountains, grocery and drug stores, convenience stores, and other small outlets; and directly to consumers through Keurig.com website. Keurig Dr Pepper Inc. was founded in 1981 and is headquartered in Frisco, Texas.
Sector
Consumer Staples
Industry
Beverages
Primary listing
Nasdaq
United States
CEO
Timothy Cofer
Founded
1981
Employees
30 600
Revenue / employee
542 582 USD
Next earnings
February 25, 2027 (estimated)
Institutional holders
- FMR LLC12.60%
- GEODE CAPITAL MANAGEMENT, LLC2.87%
- Bank of New York Mellon Corp0.52%
- Rest of the register84.01%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
37.88 USD
52-week low
24.88 USD
1-year performance
33.35%
Rising
Year-to-date performance
28.85%
Rising
Drawdown
-5.38%
Mild pullback
Position in the 52-week range
84% of range
Against the world ETF
Over 19 years, from April 2008 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned more, but shaking 10.7 times harder: for the risk taken, the ETF paid better.
$10,000 placed at the end of April 2008 are worth today
| Keurig Dr Pepper | $764,170 |
| World ETF | $44,104 |
| S&P 500 | $76,553 |
| Risk-free placement | $12,988 |
The risk
- Shaking:the share moves 10.7 times as much as the world ETF.
- Worst fall:-50Â % between April 2008 and February 2009. $10,000 placed at the top fell to $5,027. The world ETF, at worst: -50Â %. Back to its high in 7 months.
Keurig Dr Pepper earned 17 times as much as the world ETF since 2008
Value of $10,000 placed at the end of April 2008, dividends reinvested, in dollars
- Keurig Dr Pepper: $764,170
- World ETF: $44,104
- S&P 500: $76,553
- Risk-free placement: $12,988
Based on past performance. This is not a recommendation.
Range: 32.00 USD - 34.60 USD (3 methods agree)
The price implies growth of 6.39% per year; the company grows at 10.36%.
Gross margin 45.2%, net margin 7.1%, ROIC 3.5%, ROE 6.5%.
Net margin
7.12%
Fair
Sector 8.88%|S&P 13.40%
Gross margin
45.15%
Fair
Return on equity (ROE)
6.49%
Low
Sector 17.59%|S&P 17.06%
Return on invested capital (ROIC)
3.53%
Low
Free cash flow margin (FCF)
9.48%
Fair
Profit-to-cash conversion (FCF conversion)
1.33x
High
Margin stability
4.9 pts
Steady
Revenue to net income
Growth
4.6/10Revenue up 70.6% over 1 year, 7.4% a year over 5, EPS 10.4% a year over 5.
Revenue (trailing 12 months)
23.1Md USD
Revenue growth (1y)
70.55%
Hyper-growth
Revenue growth (3y)
18.11%
Solid
EPS growth (1y)
22.07%
Hyper-growth
EPS CAGR (5y)
10.36%
Strong
EPS revisions (3 months)
0.20%
Revised up
Valuation
5.1/10P/E 32.8x, forward P/E 23.0x, EV/EBITDA 11.9x, PEG 3.16. The multiple sits in the 48th percentile of its own 5-year history.
P/E (TTM)
32.8x
Expensive
Sector 19.5x|S&P 23.6x
Forward P/E
23.0x
Fair
EV / EBITDA
11.9x
Fair
Sector 11.0x|S&P 15.5x
PEG
3.16
Very expensive
Sector 0.83|S&P 0.91
Fair value (reverse DCF)
32.84 USD
Fairly priced
P/E vs its own 5-year history
among the 48% lowest valuations
In line with its history
Market cap
48.8Md USD
Financial strength
2.4/10Cash covers 3.6% of the debt, net debt/EBITDA 3.9x.
Net debt / EBITDA
3.9x
Stretched
Gearing (net debt / equity)
118.05%
Stretched
Cash
1.3Md USD
Cash / market cap
2.68%
Stretched
Cash / total debt
3.60%
Stretched
Interest coverage
6.0x
Solid
Net debt
35.0Md USD
Equity
29.6Md USD
Closed daily candles, 2 years
Last close on November 10, 2026: 37.59 USD
- MM2035.39
- MM5033.08
- MM20030.31
- RSI 1467.9
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+2.67%
200-day average slope, 3 months
+5.50%
50-day average slope, 1 month
+5.64%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
2.16 % per day
Volatility change
+27.07%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 1.56 (6) | 2.30 (20) | 26 265 (18) | 6 864 (9) | 2 242 (3) |
| 2027 | 2.22 (7) | 2.54 (20) | 29 886 (18) | 7 608 (9) | 3 132 (5) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 11, 2026.
Same sub-industry: 46 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 9633 | 7.4 | 7.5 | 65.2Md USD | 26.8x | 30.2 % | 22.5 % | 49.5 % | -0.6x | 3.2 % | -15.5 % | ||
| 2 | CCH | 6.6 | 6.3 | 20.5Md USD | 18.4x | 8.1 % | 9.2 % | 13.3 % | 0.7x | 4.2 % | 20.1 % | ||
| 3 | FEMSA UBD | 6.6 | 6.5 | 26.7Md USD | 22.2x | 3.7 % | 18.4 % | 7.4 % | 1.2x | 15.6 % | 26.0 % | ||
| 4 | AC * | 6.4 | 5.5 | 21.5Md USD | 18.7x | 8.2 % | 5.9 % | 12.1 % | 0.7x | 4.4 % | 29.0 % | ||
| 5 | MNST | 6.1 | 5.0 | 88.9Md USD | 41.3x | 22.7 % | 16.7 % | 24.7 % | -1.1x | 2.2 % | 29.3 % | ||
| 6 | PEP | 5.8 | 6.0 | 196Md USD | 18.1x | 11.1 % | 5.6 % | 17.0 % | 2.3x | 5.3 % | 0.5 % | ||
| 7 | CCEP | 5.7 | 5.9 | 51.6Md USD | 23.3x | 9.3 % | -6.0 % | 11.0 % | 2.7x | 4.8 % | 26.3 % | ||
| 8 | KDP | 5.3 | 4.0 | 48.8Md USD | 32.8x | 7.1 % | 70.6 % | 3.5 % | 3.9x | 4.5 % | 33.4 % | ||
| 9 | KO | 5.1 | 4.6 | 420Md USD | 28.8x | 28.4 % | 7.0 % | 19.7 % | 1.9x | 3.4 % | 37.5 % |
